ClinicalTrials.gg
CompletedNCT05906017Updated May 14, 2026

Open Versus Robotic-assisted Ventral Hernia Repair, Short and Long-term Outcome

An interventional study of Open Hernia surgery and Robotic Hernia surgery in Abdominal Hernia, sponsored by University of Southern Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Primary conditionHernia, VentralRegistry: Hernia, AbdominalReclassifiedWhy we changed it
Registry
Hernia, Abdominal — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hernia, Ventral
Why
  1. The study's title name Hernia, Ventral, a narrower term within Hernia, Abdominal.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Southern Denmark · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this randomized clinical trial, the investigators will compare the conventional open repair for hernia in the anterior abdominal wall with the robotic-assisted approach. 60 patients with midline abdominal wall defects will be randomized to either open or robotic-assisted surgery. The investigators will examine short and long-term complications through follow-up with clinical assessment as well as patient-reported outcome measures including pain, cosmetic appearance, and overall patient satisfaction. Furthermore, the investigators will study the difference in surgical stress response between the two methods measured from a variety of different biomarkers before and after the operation. A cost-effective analysis will be conducted for the robotic and open procedure.

Read the detailed description

Ventral hernias occur in up to 25% of the population. They are diverse in severity ranging from small umbilical hernias to large abdominal wall defects that may result in loss of domain. Approximately one-third are incisional hernias. Incisional hernias are usually more complex due to complications from previous surgery. The procedure may be complicated as a result of intraabdominal bowel adhesions and adhesions within the hernial sac. These factors cause discomfort and may complicate the repair. Ventral hernias may be repaired either through a minimally invasive laparoscopic procedure or an open approach. The laparoscopic repair was introduced in the 1990s and in 2003 the first robotic-assisted procedure was described in a porcine model. In 2012 the first series of robotic repairs were reported in humans. Due to the superior flexibility of the robotic instruments, there is a substantial interest in harnessing the advantages of the robotic platform. Because robotic repair differs in several technical aspects from the open approach, it is important to determine whether the short and long-term results differ between the two procedures. Furthermore, it remains unresolved whether the robotic procedure is able to provide comparable outcomes to the open repair when assessed for quality-of-life outcome measures. These questions are important to address in order to determine the most appropriate surgical options for individual patients.

02

Conditions studied

  • Abdominal Hernia

Browse trials for

Keywords

  • Da Vinci
  • Robot
  • Umbilical hernia
  • Ventral hernia
  • Epigastric hernia
  • Hernia repair
  • Laparotomy
03

In context

Hernia, Ventral Reclassified

230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.

This study's enrollment of 56 is below the median of 90 across 153 interventional studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

University of Southern Denmark is the lead sponsor of 336 studies on the registry; 46 are open to participants now.

Compared within Hernia, Ventral, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hernia, Abdominal. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age≥18
  • ASA 1-3
  • Clinical and radiologic diagnosis of midline ventral hernia
  • Eligible to surgery according to a preoperative anaesthetic assessment
  • Able to understand written and oral Danish language

Exclusion criteria

Exclusion Criteria:

  • Incarcerated ventral hernia requiring emergency surgery
  • Pregnancy
  • Patients with chronic pain due to arthritis, migraine or other illness requiring regular intake of analgesics (paracetamol, NSAID, opiates etc).
  • Current cancer diagnosis
  • History of psychiatric or addictive disorder that prevents the patient from participating in the trial
  • Co-existing inflammatory disease
  • Co-existing immunological disease that requires medication of any kind
  • >40 kg/m2
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Active comparator
    Open repair

    Open ventral hernia repair

    Procedure: Open Hernia surgery

  • Experimental
    Robotic-assisted repair

    Robotic-assisted ventral hernia repair

    Procedure: Robotic Hernia surgery

Interventions

  • ProcedureOpen Hernia surgery

    midline ventral hernia repair - open

  • ProcedureRobotic Hernia surgery

    midline ventral hernia repair - robotic

06

What researchers measure

Primary outcomes

  1. Length of stay (LOS)

    The primary outcome measure will be assessed by reviewing the electronic patient journal system. The day of the procedure will be recorded as day 0

    Time frame: Up until 3 months

Secondary outcomes

  1. Operating time

    Measured in minutes

    Time frame: Time from first incision to wound closure

  2. Change in Surgical stress response (CRP)

    The degree of systemic inflammatory response expressed by C- reactive protein in serum

    Time frame: measured at baseline preoperatively, 30 minutes after extubation, 120 minutes after extubation and on day 1 and 3.

  3. Hernia defect size

    Hernia defect size measured in mm either on CT scan or intraoperative.

    Time frame: Measured preoperatively

  4. Intraoperative need of blood transfusion

    The amount of blood transfused during surgery measured in mL

    Time frame: From first incision until last suture has been placed

  5. Change in surgical stress response (Interleukins)

    The degree of systemic inflammatory response expressed by cytokine levels in serum. All measurements will consist of weight/volume ratio (eg. CRP mg/L and IL-6 pg/mL)

    Time frame: Measured at baseline preoperatively and up until 120 minutes after extubation on day 1 and 3.

  6. Treatment cost

    Cost analysis of the two types of treatment

    Time frame: From inclusion until 6 months postoperatively

  7. Change in satisfaction and quality of life

    Satisfaction and quality of life were measured preoperatively at the outpatient clinic using the "abdominal hernia questionnaire" (AHQ) translated into Danish. The AHQ has 4 possible answers (All of the time, Most of the time, Some of the time, None the time OR Strongly disagree, Somewhat disagree, Somewhat agree, Strongly agree OR Very unsatisfied, Somewhat dissatisfied, Somewhat satisfied, Very satisfied)

    Time frame: [Time Frame: From inclusion until 6 months after operation.]

07

Study locations

1 site
  • Sygehus Sønderjylland
    Aabenraa, Southern Denmark 6200, Denmark
08

References and documents

Publications

  • Nielsen KA, Valorenzos A, Tsigka E, Frandsen CH, Helligso P, Petersen SR, Ellebaek MB, Nielsen MF. Open versus robotic-assisted repair of midline ventral hernias with defect width 2-8 cm - a randomized clinical trial (OVER). Hernia. 2026 Apr 2;30(1):155. doi: 10.1007/s10029-026-03617-7. PubMed 41925930 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2023 to primary completion in Apr 2025, 23 months.

Of 75 non-industry interventional studies with no phase under Hernia, Ventral, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 48. This study's 23 months is below that.

Counting every sponsor, half of 88 studies reached it within 37 months; a quarter within 19 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2023
First posted
Jun 15, 2023
StartActual
May 15, 2023
Primary completionActual
Apr 25, 2025
CompletionActual
Oct 25, 2025
Last update
May 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05906017
Responsible party
Sponsor
First posted
Jun 15, 2023
Start date
May 15, 2023
Primary completion
Apr 25, 2025
Completion
Oct 25, 2025
Last update
May 14, 2026

Study contacts

Michael Festersen Nielsen
study director · Hospital of Southern Denmark - Aabenraa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion